A tale of two tails: The importance of unstructured termini in the aggregation pathway of β2-microglobulin

Rui J S Loureiro1, Diogo Vila-Viçosa2, Miguel Machuqueiro2

  • 1BioISI - Biosystems & Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal.

Proteins
|July 27, 2017
PubMed

Insights

Molecular simulations reveal two intermediate states in human β2-microglobulin (HB2m) aggregation. The D76N mutant forms a key aggregation species (I2), explaining its higher amyloidogenic potential and identifying new aggregation hot-spots.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Computational Chemistry

Background:

  • Protein misfolding and aggregation are central to conformational disorders like amyloidosis.
  • Human β2-microglobulin (HB2m) is linked to dialysis-related amyloidosis.
  • The D76N HB2m mutant causes hereditary systemic amyloidosis, necessitating mechanistic understanding.

Purpose of the Study:

  • To investigate the early aggregation mechanisms of the D76N HB2m mutant.
  • To identify intermediate states and key aggregation species using molecular simulations.
  • To elucidate the structural basis for the enhanced amyloidogenicity of the D76N mutant.

Main Methods:

  • Discrete molecular dynamics simulations of a structure-based model.
  • Computational docking simulations.
  • Analysis of protein folding landscapes and intermediate states.

Main Results:

  • Two intermediate states (I1 and I2) were predicted in the HB2m folding landscape.
  • The D76N mutant exclusively populates the I2 intermediate, characterized by unstructured termini.
  • I2 was identified as the key aggregation species at acidic and physiological pH, explaining the mutant's higher amyloidogenic potential.
  • Specific regions (DE-loop, C-terminus, G-strand) and residues (Phe56, Asp59, Trp60, Phe62, Tyr63, Tyr66, Lys94, Trp95) were implicated in HB2m aggregation.

Conclusions:

  • The D76N mutation significantly alters the HB2m aggregation pathway by stabilizing the I2 intermediate.
  • Understanding these aggregation intermediates and hot-spots is crucial for designing targeted therapies for HB2m amyloidosis.
  • The study provides a molecular basis for the distinct clinical manifestations of D76N-related amyloidosis.

Related Concept Videos

Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
5.3K
ER Retrieval Pathway01:45

ER Retrieval Pathway

In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
4.9K
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
7.9K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.3K
Termination of Translation01:44

Termination of Translation

The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
28.2K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
5.0K